by Paul | Dec 14, 2017 | xarelto news
A victim of the famous anticoagulant drug Xarelto has just been rewarded with over $28 million in damages in a Philadelphia court. While the legal proceedings of the centralized multidistrict litigation (MDL) MDL keep moving on, this verdict was reached in a state...
by Paul | Sep 6, 2017 | xarelto news
For the third time in a row, Bayer and Janssen Pharmaceutical won the Xarelto bellwether trial scheduled for August 2017. A federal jury in the U.S. District Court, Southern District of Mississippi, handed a favorable verdict to the manufacturers against a plaintiff...
by Paul | Jun 21, 2017 | xarelto news
The second Xarelto bellwether trial ended with a victory for the defendants Johnson & Johnson and Bayer AG. The federal jury’s verdict confirmed the decision of the first trial, clearing the manufacturers of any liability for the serious injuries suffered by...
by Paul | May 16, 2017 | xarelto news
Authoritative and influential individuals recently spoke to the news about a potential Xarelto lawsuit conspiracy. Is there any truth behind their words? The Xarelto MDL is one of the largest litigation in the recent American history, racking up to 18,000 lawsuits...
by Paul | May 5, 2017 | xarelto news
The much-awaited first Xarelto bellwether trial ended with a temporary victory for the defendants Bayer and Janssen Pharmaceuticals. The federal jury in New Orleans decided in favor of the pharmaceutical companies during the first test trial against the...
by Paul | Mar 29, 2017 | xarelto news
The first Xarelto bellwether trial has been pushed by another month and is now scheduled to begin in April 2017. This is the third time both parties agree to reschedule the four trials which are now set to begin in April, May, June and July. Last time the trial was...
